{"transactions":[{"id":3626584,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":159738,"kind":"person","name":"Hasleton Mark Daniel","position":1,"cik":"0001759581","reported_name":"Hasleton Mark Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-28T21:58:02.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 4 equal installments of 5,625 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022."}],"balance_after":22500,"derivative":{"exercise_price":3.16,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001213900-19-003338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019003338/ownership.xml","form_type":"4"}}]}